-
Valo Tx Working to Develop Potential COVID-19 Vaccine
contractpharma
April 28, 2020
Will use PeptiCRAd technology with HLA-matched peptides optimized to further boost CD8+ T-cell immune responses.
-
FDA COVID-19 Update
contractpharma
April 28, 2020
FDA issues a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine.
-
Romark Initiates Trials of NT-300 for COVID-19 Prevention
contractpharma
April 28, 2020
In cell cultures, the active ingredient in NT-300, nitazoxanide, inhibits replication of a broad range of respiratory viruses, including SARS-CoV-2.
-
CTI BioPharma Initiates Phase III Pacritinib Trial in COVID-19
contractpharma
April 28, 2020
Will compare pacritinib plus standard of care versus placebo plus standard of care in 358 patients with severe COVID-19.
-
Global Cord Blood Corporation Provides Further Update on COVID-19
prnasia
April 27, 2020
Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 201
-
Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19
prnasia
April 27, 2020
Menarini Silicon Biosystems, a global leader in liquid biopsy and rare cells technologies, today announces that it is exploring the possible use of its proprietary CELLSEARCH technology to study the progression of COVID-19 disease --and to potentially ide
-
Plans afoot to develop COVID-19 vaccine at the earliest: Dr Harsh Vardhan
expresspharma
April 27, 2020
Serum Institute of India is collaborating with Oxford University to make the Covid-19 vaccine.
-
Herbal products from CIMAP may boost immunity to fight COVID-19 infection
expresspharma
April 27, 2020
It has decided to transfer the technology of its herbal products, CIM-Paushak and Herbal Cough Syrup to entrepreneurs and start-up companies.
-
Wavelength Pharmaceuticals expands supplies of key drug ingredients for critically ill COVID-19 patients
pharmaceutical-business-review
April 26, 2020
Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients (APIs), today reported that it has greatly expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients.
-
Hope Biosciences announces third FDA-approved clinical trial for COVID-19
pharmaceutical-business-review
April 26, 2020
Hope Biosciences announces FDA approval on their third clinical trial for COVID-19.This study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River Oaks Hospital and Clinics.